Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,573
Closed -$220K 170
2025
Q1
$220K Buy
1,573
+4
+0.3% +$651 0.05% 198
2024
Q4
$262K Buy
1,569
+355
+29% +$63.1K 0.06% 177
2024
Q3
$207K Buy
1,214
+98
+9% +$14.2K 0.05% 203
2024
Q2
$158K Buy
+1,116
New +$139K 0.04% 232
2023
Q3
Sell
-2,944
Closed -$351K 182
2023
Q2
$351K Buy
2,944
+11
+0.4% +$1.14K 0.09% 133
2023
Q1
$272K Buy
2,933
+10
+0.3% +$877 0.08% 150
2022
Q4
$239K Buy
+2,923
New +$222K 0.07% 163
2022
Q3
Sell
-3,329
Closed -$233K 175
2022
Q2
$233K Buy
3,329
+11
+0.3% +$805 0.07% 167
2022
Q1
$274K Buy
+3,318
New +$269K 0.07% 155
2018
Q1
Sell
-4,448
Closed -$210K 136
2017
Q4
$210K Buy
4,448
+3
+0.1% +$147 0.08% 124
2017
Q3
$215K Buy
4,445
+103
+2% +$5.13K 0.09% 117
2017
Q2
$218K Buy
+4,342
New +$198K 0.1% 113
2015
Q2
Sell
-5,078
Closed -$219K 114
2015
Q1
$219K Buy
5,078
+3
+0.1% +$130 0.11% 103
2014
Q4
$228K Buy
+5,075
New +$207K 0.12% 92

Other funds holding ORCL

The Family Firm's ORCL Position: Q2 2025 in Review

The Family Firm sold out of Oracle (ORCL) in Q2 2025, closing a stake of 1,573 shares — an estimated $220K sold.

The Family Firm first reported a position in ORCL in Q4 2014 and held it in 14 quarters. The position peaked at $351K in Q2 2023. 3,617 funds tracked by Wall St. Rank hold ORCL as of Q2 2025.

  • The Family Firm reported no remaining Oracle position as of Q2 2025 after selling out during the quarter.
  • The Family Firm sold 1,573 Oracle shares in Q2 2025, an estimated $220K.
  • The Family Firm first reported a position in Oracle in Q4 2014 and held it in 14 quarters.
  • The Family Firm's Oracle position peaked at $351K in Q2 2023.
  • 3,617 funds tracked by Wall St. Rank held Oracle as of Q2 2025.

Based on The Family Firm's 13F filing for Q2 2025, filed 8 Aug 2025.